Supplemental Material, DS_10.1177_0363546520920591 - The Use of Recombinant Human Growth Hormone to Protect Against Muscle Weakness in Patients Undergoing Anterior Cruciate Ligament Reconstruction: A Pilot, Randomized Placebo-Controlled Trial

Mendias, Christopher L.; Enselman, Elizabeth R. Sibilsky; Olszewski, Adam M.; Gumucio, Jonathan P.; Edon, Daniel L.; Konnaris, Maxwell A.; Carpenter, James E.; Awan, Tariq M.; Jacobson, Jon A.; Gagnier, Joel J.; Barkan, Ariel L.; Bedi, Asheesh

doi:10.25384/SAGE.12377621.v1

DS_10.1177_0363546520920591.pdf (219.5 kB)

Supplemental Material, DS_10.1177_0363546520920591 - The Use of Recombinant Human Growth Hormone to Protect Against Muscle Weakness in Patients Undergoing Anterior Cruciate Ligament Reconstruction: A Pilot, Randomized Placebo-Controlled Trial

journal contribution

posted on 2020-05-27, 12:13 authored by Christopher L. Mendias, Elizabeth R. Sibilsky Enselman, Adam M. Olszewski, Jonathan P. Gumucio, Daniel L. Edon, Maxwell A. Konnaris, James E. Carpenter, Tariq M. Awan, Jon A. Jacobson, Joel J. Gagnier, Ariel L. Barkan, Asheesh Bedi

Supplemental Material, DS_10.1177_0363546520920591 for The Use of Recombinant Human Growth Hormone to Protect Against Muscle Weakness in Patients Undergoing Anterior Cruciate Ligament Reconstruction: A Pilot, Randomized Placebo-Controlled Trial by Christopher L. Mendias, Elizabeth R. Sibilsky Enselman, Adam M. Olszewski, Jonathan P. Gumucio, Daniel L. Edon, Maxwell A. Konnaris, James E. Carpenter, Tariq M. Awan, Jon A. Jacobson, Joel J. Gagnier, Ariel L. Barkan and Asheesh Bedi in The American Journal of Sports Medicine